Pharma Journalist -

Pandion Therapeutics declared the completion of a $58 million Series A financing that will be utilized to further its drug programs for autoimmune and inflammatory diseases in addition…
Read More...

A Gilead Company, Kite ventures into Clinical Trial collaboration with  Pfizer, enabling assessment of the efficacy of the investigational combination of Yescarta (axicabtagene…
Read More...

Makers of the the Prenate line of prescription prenatal vitamins, Avion Pharmaceuticals sought approval of its New Drug application for the Oral Contraceptive Balcoltra (levonorgestrel…
Read More...

Clinical stage company, Relmada Therapeutics into developing novel therapies for treating Centralnervous system diseases obtained global rights to develop and market dextromethadone…
Read More...

Molecule discovery specialist X-Chem, proclaimed a remarkable extension of their present drug discovery collaboration with AstraZeneca. The agreement focuses on the synthesis and…
Read More...

Eiger Biopharmaceuticals displaying forte in development and commercialization of targeted therapies for rare diseases declared negative results for Phase 2 LIBERTY study in pulmonary…
Read More...

Marina Biotech, a biopharmaceutical company committed to the development and commercialization of advanced therapeutics for hypertension, arthritis, pain and oncology embarked on a…
Read More...

Digital patient decision support platform, WiserCare declared the appointment of Daniel J. Castillo as its Chief Executive Officer.  He brings with him profound experience and knowledge…
Read More...

A biotech company that designs and develops virus-based  immunotherapies, Transgene confirms dosing the first patient in  a Phase 1 Clinical Trial in China, evaluating T101, therapeutic…
Read More...

Ipsen bio-pharmaceuticals set to present five new sub-analyses of the pivotal Phase 3 NAPOLI-1 trial at this year's American Society of Clinical Oncology’s Gastrointestinal Cancer…
Read More...